Exponent Sees Q3 FY26 Revenue Before Reimbursements Growth Of 8%-10%; Raises FY26 Revenue Before Reimbursements Growth View To 9%-10%
Exponent (NASDAQ:EXPO) expects third-quarter fiscal 2026 revenues before reimbursements to increase 8% to 10% year over year. The company also raised its full-year fiscal 2026 outlook and now expects revenues before
Exponent said its business is growing a little faster than expected, so they feel more confident about their full year ahead. When a company raises its outlook, it usually means things are going better than they thought—that's worth noticing.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.